Rho GTPases in primary brain tumor malignancy and invasion Bassem D. KhalilMirvat El-Sibai Topic Review 19 April 2012 Pages: 333 - 339
Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays Zhiquan JiangSongbai GuiYazhuo Zhang Laboratory Investigation 16 May 2012 Pages: 341 - 348
Aurora kinase B/C inhibition impairs malignant glioma growth in vivo Roberto Jose DiazBrian GolbournJames T. Rutka Laboratory Investigation 01 March 2012 Pages: 349 - 360
Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors Shingo TakanoYukinari KatoAkira Matsumura Laboratory Investigation 07 March 2012 Pages: 361 - 373
PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas Pramila RamaniAimie NortonMargaret T. May Laboratory Investigation 01 March 2012 Pages: 375 - 383
t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65 Junyang LiHongyi LiuWeixing Hu Laboratory Investigation 02 March 2012 Pages: 385 - 393
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas Gordon LiSiddhartha S. MitraAlbert J. Wong Laboratory Investigation 02 March 2012 Pages: 395 - 402
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas Tareq A. JuratliMatthias KirschDietmar Krex Laboratory Investigation 13 March 2012 Pages: 403 - 410
Development of a novel animal model to differentiate radiation necrosis from tumor recurrence Sanath KumarAli S. ArbabStephen L. Brown Laboratory Investigation 10 March 2012 Pages: 411 - 420
Erratum to: Development of a novel animal model to differentiate radiation necrosis from tumor recurrence Sanath KumarAli S. ArbabStephen L. Brown Erratum 24 April 2012 Pages: 421 - 421
Overactivation of Ras signaling pathway in CD133+ MPNST cells Emma Borrego-DiazKaoru TeraiFaris Farassati Laboratory Investigation 08 April 2012 Pages: 423 - 434
Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression Soma GhasimiHannu HaapasaloUlrika Andersson Laboratory Investigation 08 April 2012 Pages: 435 - 441
Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells Martin HeftiIna AlbertVera Luginbuehl Laboratory Investigation 15 April 2012 Pages: 443 - 450
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy Marta SimóRoser VelascoJordi Bruna Clinical Study 10 March 2012 Pages: 451 - 458
Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system Shirley AbrahamNan HuRandy Jensen Clinical Study 06 March 2012 Pages: 459 - 468
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation L. L. TsaiL. DrubachN. J. Ullrich Clinical Study 11 March 2012 Pages: 469 - 475
Assessment of intra-observer variability in measurement of high-grade brain tumors James M. ProvenzaleMichael C. Mancini Clinical Study 10 March 2012 Pages: 477 - 483
Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH–cortisol and renin–angiotensin–aldosterone Changxin HuangYiqian JiangXuechun Wang Clinical Study 24 March 2012 Pages: 485 - 490
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study Whitney B. PopeXin Joe QiaoTimothy Cloughesy Clinical Study 18 March 2012 Pages: 491 - 498
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma David A. ReardonJames J. VredenburghHenry S. Friedman Clinical Study 10 March 2012 Pages: 499 - 506
Stereotactic radiosurgery for patients with recurrent intracranial ependymomas Michael C. StauderNadia NI LaackBruce E. Pollock Clinical Study 23 March 2012 Pages: 507 - 512
FABP4 is a candidate marker of cerebellar liponeurocytomas Elena AnghileriMarica EoliGaetano Finocchiaro Clinical Study 03 April 2012 Pages: 513 - 519
Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy Christopher M. McPhersonMargie Gerena-LewisRonald E. Warnick Clinical Study 01 April 2012 Pages: 521 - 525
Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis Teneille E. GoftonJerome GraberAlan Carver Clinical Study 31 March 2012 Pages: 527 - 534
Stereotactic radiosurgery for intracranial chondrosarcoma Aditya IyerHideyuki KanoL. Dade Lunsford Clinical Study 11 April 2012 Pages: 535 - 542
Sleep dysfunction in long term survivors of craniopharyngioma Peter E. ManleyKiera McKendrickNicole J. Ullrich Clinical Study 19 April 2012 Pages: 543 - 549